Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 8/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 10/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15871669 | 0.85 | GRM4 (0.38) | GRM4CYP1A2CYP2C19KMT2A | |
| SCHEMBL2948463 | 0.80 | KDM4E (0.51) | GRM4CYP1A2CYP2C19ALDH1A1KMT2A | |
| SCHEMBL1476570 | 0.76 | PIM1 (0.35) | KIF11GRM4MITFALDH1A1TP53 | |
| SCHEMBL19083038 | 0.75 | GRM4 (0.35) | GRM4CYP1A2CYP2C19SCN9AKMT2A | |
| SCHEMBL2945434 | 0.75 | KDM4E (0.51) | GRM4CYP1A2CYP2C19ALDH1A1KMT2A | |
| SCHEMBL15871661 | 0.75 | GRM4 (0.32) | GRM4CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL19083040 | 0.73 | CYP17A1 (0.34) | KIF11MITFALDH1A1TP53KMT2A | |
| SCHEMBL9051628 | 0.72 | ALDH1A1 (0.61) | KIF11MITFALDH1A1TP53KMT2A | |
| SCHEMBL25443140 | 0.71 | KMT2A (0.39) | KIF11SCN9AALDH1A1KMT2A | |
| SCHEMBL17254410 | 0.70 | NPSR1 (0.40) | KIF11MITFALDH1A1TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170194578-A1 | PLATINUM COMPLEX AND OLED USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2017-07-06 | — | — | US | disclosed |
| US-20170194578-A1 | PLATINUM COMPLEX AND OLED USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194578-A1 | PLATINUM COMPLEX AND OLED USING THE SAME | OCIAD2, POF1B, OCIAD1 | KIF11 3327/4885GRM4 813/4885CYP1A2 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.